M. Bagot
0000-0002-1631-5192
Publication & Citation Trends
Publications
0 total
Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Cited by 1
Semantic Scholar
ONGOING PHASE 2, OPEN‐LABEL, MULTICENTER, SINGLE‐ARM STUDY ASSESSING AN EVERY‐4‐WEEK DOSING SCHEDULE OF MOGAMULIZUMAB IN CUTANEOUS T‐CELL LYMPHOMA: PRELIMINARY RESULTS
Cited by 0
Semantic Scholar
A Phase 2, multicenter, open-label, single-arm study assessing a 4-weekly dosing schedule for mogamulizumab in patients with mycosis fungoides/Sézary syndrome (MOGA-2MG-Q4W)
Cited by 0
Semantic Scholar
LACUTAMAB IN PATIENTS WITH RELAPSED AND REFRACTORY SéZARY SYNDROME: LONG TERM FOLLOW‐UP FROM THE TELLOMAK PHASE 2 TRIAL
Cited by 0
Semantic Scholar
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.
Cited by 1
Semantic Scholar
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
Cited by 2
Semantic Scholar
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Cited by 6
Semantic Scholar
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides - a modified Delphi consensus. Part 1: Diagnosis and staging.
Cited by 2
Semantic Scholar
Research Topics
Cutaneous lymphoproliferative disorders research
(452)
Lymphoma Diagnosis and Treatment
(200)
Fungal Infections and Studies
(110)
CAR-T cell therapy research
(109)
Nail Diseases and Treatments
(92)
Affiliations
Université Claude Bernard Lyon 1
Université Paris-Sud
University of London Institute in Paris
University of Copenhagen
European Organisation for Research and Treatment of Cancer